Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
AssigneeGenome Therapeutics Corporation
InventorsGary L. Breton, Mark Osborne
Life of this patent
Estimating the term…
Abstract
The invention provides isolated polypeptide and nucleic acid sequences derived from Klebsiella pneumoniae that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the polypeptides. The invention also provides methods for the detection, prevention and treatment of pathological conditions resulting from bacterial infection.
Claims14
An isolated nucleic acid molecule encoding a K. pneumoniae polypeptide of SEQ ID NO:
- 10697.
An isolated nucleic acid consisting of SEQ ID NO:
- 3526.
An isolated nucleic acid of at least about 40 consecutive nucleotides in length, wherein the isolated nucleic acid is a fragment SEQ ID NO:
- 3526.
An isolated nucleic acid molecule of at least about 40 consecutive nucleotides in length, wherein the isolated nucleic acid molecule hybridizes under conditions of high stringency to an isolated nucleic acid consisting of SEQ ID NO:
- 3526.
An isolated nucleic acid consisting of SEQ ID NO:
- 3526.
A recombinant expression vector comprising SEQ ID NO:
- 3526 operably linked to a transcription regulatory element.
A cell comprising a recombinant expression vector, wherein the recombinant expression vector includes SEQ ID NO:
- 3526 operably linked to a transcription regulatory element.
An isolated nucleic acid molecule that hybridizes under conditions of high stringency to SEQ ID NO:3526, wherein the isolated nucleic acid molecule is at least about 40 consecutive nucleotides in length.
A recombinant expression vector comprising an isolated nucleic acid sequence operably linked to a transcription regulatory element, wherein the isolated nucleic acid sequence hybridizes under conditions of high stringency to SEQ ID NO:3526 and is at least about 40 consecutive nucleotides in length.
A cell comprising a recombinant expression vector, wherein the recombinant expression vector includes an isolated nucleic acid sequence operably linked to a transcription regulatory element, wherein the isolated nucleic acid sequence hybridizes under conditions of high stringency to SEQ ID NO:3526 and is at least about 40 consecutive nucleotides in length.
Dependencies are inferred from the claim text.